Protective role of human beta-defensin-2 and cathelicidin in high risk close household contacts of pulmonary tuberculosis

Sudhasini Panda , Shah Faisal , Diravya M Seelan , Manisha Dagar , Lokesh Mandlecha , Vidushi Varshney , Mridul Sharma , Kalpana Luthra , Neeraj Kumar Gupta , Archana Singh
{"title":"Protective role of human beta-defensin-2 and cathelicidin in high risk close household contacts of pulmonary tuberculosis","authors":"Sudhasini Panda ,&nbsp;Shah Faisal ,&nbsp;Diravya M Seelan ,&nbsp;Manisha Dagar ,&nbsp;Lokesh Mandlecha ,&nbsp;Vidushi Varshney ,&nbsp;Mridul Sharma ,&nbsp;Kalpana Luthra ,&nbsp;Neeraj Kumar Gupta ,&nbsp;Archana Singh","doi":"10.1016/j.clicom.2023.02.006","DOIUrl":null,"url":null,"abstract":"<div><p>Host-defense peptides (HDPs) such as human beta-defensin-2 (hBD-2) and cathelicidin (LL37) are essential components of innate immune response against tuberculosis (TB) infection, which could also be assessed for diagnostic potential in spectrum of TB infection. We assessed mRNA and circulating levels of HDPs in pulmonary TB (PTB) patients and their household contacts (HHCs). hBD-2 and LL37 were found to be significantly higher in both PTB and HHCs suggestive of bacterial exposure which was further corroborated by higher levels of HDPs in mantoux positive HHCs (latent TB). Higher levels of HDPs in HHCs may suggest protective host response against infection as indicated by inverse relation of LL37 with disease severity in PTB. Both peptides demonstrated high levels of sensitivity and specificity, although hBD-2 proved to be a better HDP for distinguishing LTBI from active TB at a cutoff of 3904 pg/ml. However, follow-up studies are required to validate these findings.</p></div>","PeriodicalId":100269,"journal":{"name":"Clinical Immunology Communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Immunology Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772613423000057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Host-defense peptides (HDPs) such as human beta-defensin-2 (hBD-2) and cathelicidin (LL37) are essential components of innate immune response against tuberculosis (TB) infection, which could also be assessed for diagnostic potential in spectrum of TB infection. We assessed mRNA and circulating levels of HDPs in pulmonary TB (PTB) patients and their household contacts (HHCs). hBD-2 and LL37 were found to be significantly higher in both PTB and HHCs suggestive of bacterial exposure which was further corroborated by higher levels of HDPs in mantoux positive HHCs (latent TB). Higher levels of HDPs in HHCs may suggest protective host response against infection as indicated by inverse relation of LL37 with disease severity in PTB. Both peptides demonstrated high levels of sensitivity and specificity, although hBD-2 proved to be a better HDP for distinguishing LTBI from active TB at a cutoff of 3904 pg/ml. However, follow-up studies are required to validate these findings.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人β-防御素-2和组织蛋白酶对肺结核高危家庭密切接触者的保护作用
宿主防御肽(HDPs),如人β-防御素-2(hBD-2)和组织蛋白酶(LL37),是抵抗结核病(TB)感染的先天免疫反应的重要组成部分,也可以评估其在结核病感染谱中的诊断潜力。我们评估了肺结核(PTB)患者及其家庭接触者(HHC)中HDPs的mRNA和循环水平。发现hBD-2和LL37在PTB和HHCs中均显著升高,提示细菌暴露,mantoux阳性HHCs(潜伏性TB)中较高水平的HDPs进一步证实了这一点。HHCs中较高水平的HDPs可能表明宿主对感染的保护性反应,如LL37与PTB疾病严重程度的反比关系所示。尽管hBD-2在3904 pg/ml的临界值下被证明是区分LTBI和活动性TB的更好的HDP,但这两种肽都表现出高水平的敏感性和特异性。然而,需要进行后续研究来验证这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
CRISPR/Cas9-mediated RELA and RELC knockout in human regulatory T cells abrogates FOXP3 expression and suppressive function Deficiency of interleukin-1 receptor antagonist: An updated review of the pathogenesis, clinical characteristics, and treatments First report of Mycobacterium chimaera infection in a patient with chronic granulomatous disease Chronic disseminated histoplasmosis in a patient on fingolimod therapy: A case report and review of literature Editorial Board
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1